COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD117+ CELLS

Human antibodies to Hemolysin A toxin

Human endothelin receptor antibody and use thereof

MDR immunogen

Combined immunoassay and magnetic immunoassay methods for extended range of sensitivity

ENTPD2 antibodies, combination therapies, and methods of using the antibodies and combination therapies

Antibody Fc Mutants with Ablated Effector Functions

Anti-CD40 antibodies and uses thereof

Anti-CD27 antibodies and uses thereof

Methods of treating a subject having an EGFR-positive and/or ErbB-3-positive tumor

Antibodies directed to Tie-2 and methods of use

Variant CD3-binding domains and their use in combination therapies for the treatment of disease

Anti-human LAG-3 monoclonal antibody and use thereof

IL-1β neutralizing human monoclonal antibodies

IL-1β neutralizing human monoclonal antibodies

Monoclonal antibody against nerve growth factor, and encoding gene and use thereof

Composition and method for the diagnosis and treatment of iron-related disorders

Human immunodeficiency virus neutralizing antibodies

Oxadiazole linkers and use thereof

COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS

Targeted liposomal gemcitabine and methods thereof

TEST FOR DETECTING MALIGNANT KIDNEY CANCER

ANTIBODIES AND USES THEREOF

Anti-GITR antibodies and uses thereof

Anti-CD123 antibodies and conjugates and derivatives thereof

Anti-EGFRvIII antibodies and uses thereof

Anti-HLA-G antibodies and methods of use thereof

ANTIGEN BINDING PROTEINS WHICH BIND TO THE pMHC HLA-DQ2.5:DQ2.5 PRESENTING A GLIADIN PEPTIDE

ANTIGEN-BINDING PROTEINS TARGETING SHARED ANTIGENS

Human PD-L1-binding immunoglobulins

Anti-CD8 antibodies and uses thereof

Anti-ROR1 antibodies and uses thereof

Antigen binding proteins that bind PD-L1

AGONISTIC ANTIBODIES THAT BIND CD40

Antibodies and molecules that immunospecifically bind to BTN1A1 and the therapeutic uses thereof

Lymphocyte activation gene-3 (LAG-3) binding antibody and use thereof

Nucleic acids encoding anti-VEGF-A antibodies and uses thereof

Polynucleotides for preparing ANGPTL 3/8 complexes

Methods of binding amyloid beta protein having pyroglutamate at the third amino acid residue (3pE abeta) in vivo using anti-3pE abeta antibodies or antigen-binding fragments thereof

SPNS2 neutralizing antibody

Agents, uses and methods for the treatment of synucleinopathy

BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND A STAPHYLOCOCCUS TARGET ANTIGEN AND A COMPLEMENT COMPONENT AND USES THEREOF

Middle east respiratory syndrome coronavirus neutralizing antibodies and methods of use thereof

IgG-binding peptide, and specific modification of antibody with said peptide

Methods of immunosuppression comprising administering an anti-CD154 antibody

Anti-human IgG4 monoclonal antibody and methods of making and using same

MECHANISM OF ACTION

Bio-responsive adhesive antibody delivery platform for immunotherapy and preparation method thereof

Anti-NGly-1 antibodies and methods of use

Anti-HER2 antibodies

COMPOSITIONS OF ANTIBODY CONSTRUCT-AGONIST CONJUGATES AND METHODS OF USE THEREOF

ANTIBODY FC VARIANTS

Anti-PODXL antibody MAI1738 and its use for cancer treatment

Optimized Fc variants

Antibodies to CD40 with enhanced agonist activity

FC binding fragments comprising a PD-L1 antigen-binding site

ANTI-VISTA ANTIBODIES AND METHODS OF USE

Antibodies specific to glycosylated PD-1 and methods of use thereof

Amino acid sequences that modulate the interaction between cells of the immune system

Anti-CD33 antibodies and methods of use thereof

Tau-binding antibodies

Anti-tau antibodies and methods of use

Humanized anti-Tau(pS422) antibodies and methods of use

Filamin A binding proteins and uses thereof

METHODS AND COMPOSITIONS FOR TREATING YELLOW FEVER

Interleukin-2 muteins for the expansion of T-regulatory cells

ANTIBODY-DRUG CONJUCATES AND THEIR USES FOR THE TREATMENT OF CANCER

Calreticulin binding constructs and engineered T cells for the treatment of diseases

Site-specific antibody-drug glyconjugates and methods

ANTIBODY

Anti-KLK7 antibodies, anti-KLK5 antibodies, multispecific anti-KLK5/KLK7 antibodies, and methods of use

Monoclonal antibody specifically binding to MRS

Anti-BCMA antibodies and treatment methods

N-terminal scFv multispecific binding molecules

TGFßR1 INHIBITOR-ASGR ANTIBODY CONJUGATES AND USES THEREOF

PROTEINS BINDING CD33, NKG2D AND CD16

Methods of using bispecific molecules having immunoreactivity with PD-1 and CTLA-4

Antigen binding proteins that bind PD-1

Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and methods of treatment using same

EGFL6 specific monoclonal antibodies and methods of their use

Antibodies recognizing tau

Compositions and methods for the treatment of neuromyelitis optica

High-affinity capsule-specific human monoclonal antibody

METHODS FOR PRODUCING BIOTHERAPEUTICS WITH INCREASED STABILITY BY SEQUENCE OPTIMIZATION

Methods for treating disease using inhibitors of bone morphogenetic protein 6 (BMP6)

Monoclonal antibodies that bind human CD161

Anti-PD-L1 antibodies and use thereof

ANTI-MS4A6A ANTIBODIES AND METHODS OF USE THEREOF

Anti-BMP10 monoclonal antibody or fragment thereof

Anti-Tau antibodies and methods of use

Binding molecules that specifically bind to tau

Methods of producing anti-C5 antibodies

Fc FUSION PROTEINS COMPRISING NOVEL LINKERS OR ARRANGEMENTS

Anti-MASP-1 antibodies and methods of use

ANTIBODIES SPECIFIC TO HUMAN POLIOVIRUS RECEPTOR (PVR)

Anti-EGFR antibody polypeptide

Recombinant protein targeting PD-1 and TGFß

NOVEL BISPECIFIC PD-1/LAG-3 ANTIBODY MOLECULES

Human monoclonal antibodies against LAG3 and uses thereof

Antibody binding specifically to ECL-2 of claudin 3, fragment thereof, and use thereof

Anti-human beta klotho antibody or binding fragment thereof and methods of their use

Anti-IL-23p19 antibody and use thereof in treating diseases

ANTI-IL-27 ANTIBODIES AND USES THEREOF

Optimized variants of anti-VEGF antibodies

TRISPECIFIC INHIBITORS FOR CANCER TREATMENT

Tau-binding antibodies

Methods and compositions for targeting polyubiquitin

Aggrecan binding immunoglobulins

Antibodies that neutralize RSV, MPV and PVM and uses thereof

CONJUGATES AND METHODS OF USE THEREOF FOR SELECTIVE DELIVERY OF IMMUNE-MODULATORY AGENTS

SEPARATION MOIETIES AND METHODS OF USE THEREOF

PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES

A METHOD FOR OPTIMIZING ANTIBODY EXPRESSION

Compound targeting IL-23A and B-cell activating factor (BAFF) and uses thereof

Constructs specifically recognizing glypican 3 and uses thereof

Anti-presepsin antibody

Cells expressing chimeric activating receptors and chimeric stimulating receptors and uses thereof

Anti-alpha-synuclein antibodies

Catheter package including catheter straightening means

ADAM6 mice

ADAM6 mice

Antibodies that bind CD3 epsilon

Variant nucleic acid libraries for CRTH2

Heterodimeric antibodies that bind CD3 and tumor antigens

COVALENT MULTI-SPECIFIC ANTIBODIES

Antibodies that specifically bind PD-1 and methods of use

Tissue factor pathway inhibitor antibodies and uses thereof

FIXaxFX bispecific antibody with common light chain

CD83 BINDING PROTEINS AND USES THEREOF

Glucocorticoid-induced tumor necrosis factor receptor (GITR) antibodies and methods of use thereof

B7-H3 antibody, antigen-binding fragment thereof and medical use thereof

Anti-TREM1 antibodies and related methods

Multi-specific binding proteins that bind CD33, NKG2D, and CD16, and methods of use

Engineered T cell receptors and immune therapy using the same

Anti-CXCR5 antibodies and compositions and uses thereof

High Affinity Human Antibodies to Human Angiopoietin-2

Anti-GDF-15 antibodies

Treatment of central nervous system disorders by intranasal administration of immunoglobulin g

Anti-alpha synuclein antibodies

Broadly neutralizing anti-HIV-1 antibodies that bind to an N-glycan epitope on the envelope

Chimeric antibody/T-cell receptor constructs and uses thereof

Motile sperm domain containing protein 2 and cancer

Antibody drug conjugates (ADC) that bind to 158P1D7 proteins

Anti-CD39 antibody compositions and methods

Anti-galectin-1 (Gal1) monoclonal antibodies and fragments thereof for neutralizing Gal1

Antibodies and variants thereof against TIGIT

Anti-CEACAM antibodies and uses thereof

Anti-Siglec-9 antibodies and methods of use thereof

Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof

Antibody molecules for cancer treatment

Methods of lowering triglyceride levels with an ANGPTL8-binding antibody or antigen-binding fragment thereof

BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES AND THEIR USE IN THE TREATMENT OF OCULAR VASCULAR DISEASES

Anti-dengue virus antibodies, polypeptides containing variant FC regions, and methods of use

Immunoglobulins and uses thereof

Method of identifying potential inhibitors of APO TNFα trimers

Methods and compositions for treating pain associated with inflammation

PLASMA KALLIKREIN BINDING PROTEINS AND USES THEREOF IN TREATING HEREDITARY ANGIOEDEMA

Methods and materials for treating cancer

Combination therapy of T cell activating bispecific antigen binding molecules and PD-1 axis binding antagonists

COMPOUNDS WHICH SPECIFICALLY BIND TO CD38 FOR USE IN THE TREATMENT OF NEURODEGENERATIVE AND INFLAMMATORY DISEASES

Nucleic acids encoding anti-OX40L antibodies

USE OF ANTI-IL-36R ANTIBODIES FOR TREATMENT OF GENERALIZED PUSTULAR PSORIASIS

Autoimmune suppressor and application thereof

Anti-MET agonist antibody for use in the treatment of colorectal cancer

Anti-frizzled antibodies and methods of use

Hybridoma clones, monoclonal antibodies to VSIG-4, and methods of making and using

FC VARIANTS WITH REDUCED EFFECTOR FUNCTION

Treatment with anti-KIR3DL2 agents

Anti-TIGIT antibodies and uses thereof

Anti-CXCL13 antibodies and methods of using the same

Cyclic compound/peptide comprising an A-beta13-16 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-beta13-16 peptide

Cyclic compound/peptide comprising an A-beta15-18 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-BETA15-18 peptide

Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly

Antigen-binding molecule capable of binding two or more antigen molecules repeatedly

DUAL TARGETING

Methods of Generating Bioactive Peptide-bearing Antibodies and Compositions Comprising the Same

Anti-CD63 antibodies, conjugates, and uses thereof

Humanized antibodies against CD269 (BCMA)

Methods for treating cancer by achieving therapeutically effective doses of anti-CD47 antibody

Anti-LRP5/6 antibodies and methods of use

TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS USING ANTIBODIES THAT BIND INTERLEUKIN-17A (IL-17A)

Anti-GM-CSF antibodies and uses thereof

Anti-angiopoietin-2 antibodies that induce Tie2 activation

LONG-ACTING AND LOW-TOXIC RECOMBINANT ANTI-VEGF HUMANIZED MONOCLONAL ANTIBODY AND PRODUCTION METHOD THEREFOR

Anti-VEGF antibodies and methods of use

Erythrocyte-binding therapeutics

Anti-MS4A4A antibodies and methods of use thereof

Antibodies against infectious diseases

Neutralizing anti-influenza binding molecules and uses thereof

Neutralizing antibodies to ebola virus glycoprotein and their use

Radiolabeled MET binding proteins for immuno-PET imaging and methods of use thereof

Methods for inhibiting fibrosis in a subject in need thereof

Antibodies to carcinoembryonic antigen-related cell adhesion molecule (CEACAM)

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

Anti-BACE1 antibodies and methods of use thereof

Anti-CD73 antibodies and compositions

ANTI-C5AR ANTIBODY AND PREPARATION METHOD AND USE THEREOF

Anti-GITR antibodies and methods of use thereof

Method for treating a neurodegenerative disease by administering an anti-cellular prion protein (PrP) antibody

ANTI-CD47 ANTIBODIES THAT DO NOT CAUSE SIGNIFICANT RED BLOOD CELL AGLLUTINATION

Use of anti-family with sequence similarity 19, member A5 antibodies for the treatment of neuropathic pain

Constructs having a SIRP-alpha domain or variant thereof

Antibody-drug conjugates and uses thereof

CONJUGATED COMPOUNDS COMPRISING CYSTEINE-ENGINEERED ANTIBODIES

Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttles

Materials and methods for performing histochemical assays for human pro-epiregulin and amphiregulin

Antibodies with modulated glycan profiles

Trispecific and/or trivalent binding proteins

Anti-thymidine kinase antibodies

Anti-PD-1 antibodies

ANTIBODIES TARGETING, AND OTHER MODULATORS OF, AN IMMUNOGLOBULIN GENE ASSOCIATED WITH RESISTANCE AGAINST ANTI-TUMOUR IMMUNE RESPONSES, AND USES THEREOF

Nucleic acids encoding anti-PAR2 antibodies and uses thereof

VEGF/DLL4 binding agents and uses thereof

Anti-IL-2 antibodies and compositions and uses thereof

Polypeptide and antibody bound to polypeptide

Agents, uses and methods for the treatment of synucleinopathy

Chemoenzymatic glycoengineering of antibodies and Fc fragments thereof

Method of treating lower back pain

Antibodies that bind human C6 and uses thereof

Tau imaging ligands and their uses in the diagnosis and treatment of tauopathy

Modified NK-92 cells for treating cancer

Antibodies to matrix metalloproteinase 9

Compositions for inhibiting MASP-2 dependent complement activation

Factor X binders enhancing FX activation

Antibodies to tumour antigens

ANTIBODIES BINDING TO GPRC5D

Antagonistic CD40 monoclonal antibodies and uses in treating immune responses

Anti-CD137 antibodies for combination with anti-PD-L1 antibodies

Therapeutic antibodies and their uses

Anti-CD25 antibody agents

Antibody variable domains targeting the NKG2D receptor

Anti HLA-G specific antibodies

CD3 ANTIGEN BINDING FRAGMENTS AND COMPOSITIONS COMPRISING SAME

Monoclonal antibodies targeting killer immunoglobulin-like receptor (KIR) family signaling

Anti-PD-L1 antibodies and uses thereof

Single-domain antibodies and variants thereof against TIGIT

Anti-CD47 antibodies and uses thereof

DETECTION OF PANCREATIC CANCER WITH AN ENGINEERED ANTI-THY1 SINGLE-CHAIN ANTIBODY

ANTIBODIES AGAINST KIDNEY ASSOCIATED ANTIGEN 1 AND ANTIGEN BINDING FRAGMENTS THEREOF

Compound targeting IL-23A and TNF-alpha and uses thereof

Anti-family with sequence similarity 19, member A5 antibodies and method of use thereof

Monoclonal antibodies to growth and differentiation factor 15 (GDF-15)

Factor H potentiating antibodies and uses thereof

Agents, uses and methods for the treatment of synucleinopathy

Human antibodies to Bet v 1 and methods of use thereof

HIGHLY SPECIFIC ZIKA NEUTRALIZING HUMAN ANTIBODIES

FORMULATION OPTIMIZATION FOR BISPECIFIC ANTIBODIES

PEPTIDES OF PAGE5

PEPTIDES

Stabilized immunoglobulin domains

Methods for treatment using anti-alpha4beta7 antibody

GENETICALLY MODIFIED NON-HUMAN ANIMALS FOR GENERATING THERAPEUTIC ANTIBODIES AGAINST PEPTIDE-MHC COMPLEXES, METHODS OF MAKING AND USES THEREOF

DLL3 binding proteins and methods of use

Methods for treating conditions associated with MASP-2 dependent complement activation

ANTI-PLA2-GIB ANTIBODIES AND THE USES THEREOF

METHOD FOR GENERATING ANTIBODIES WITH IMPROVED SPECIFICITY AND/OR AFFINITY

Bi-specific anti-CGRP receptor/PAC1 receptor antigen binding proteins and uses thereof

Anti-CD25 for tumour specific cell depletion

MICA/B ANTIBODIES AND METHODS OF USE

Canine antibody therapeutic for treating cancer

Bispecific anti-CD3 antibodies, bispecific activatable anti-CD3 antibodies, and methods of using the same

Anti-DLL3 antibodies and uses thereof

LTBP complex-specific inhibitors of TGFβ and uses thereof

DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EFFICACY AND DECREASED TOXICITY

Methods for using anti-myostatin antibodies

Anti-CTLA-4 antibodies and uses thereof

Antibodies to canine interleukin-4 receptor alpha

Anti-CD25 for tumour specific cell depletion

IL-23R antagonists to reprogram intratumoral T regulatory cells into effector cells

Monoclonal antibodies to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)

Immunotoxin for treating cancer

Method of treating autoimmune disease with antibodies against IL-33

Antigen binding molecule formats

Nucleic acids encoding bispecific anti-VEGF and anti-ANG2 antibodies and uses thereof

Treating refractory migraine

Treating refractory migraine

DKK1 antibodies and methods of use

Humanized antibodies

Multi-Specific Molecules

ANTIBODIES TO MICA AND MICB PROTEINS

Method for Delivering Drug to Muscle

Compositions comprising cyclic peptides derived from an A-beta peptide

RECRUITING AGENT FURTHER BINDING AN MHC MOLECULE

Anti-C1S antibodies and methods of use

Antigen binding proteins specifically binding MAGE-A

Dual-function antibodies targeting VEGFR2 and VEGFR3

EGFRVIII ANTIBODY AND CONJUGATE, AND PREPARATION METHOD AND USE THEREOF

ANTI-PD-L1 ANTIBODIES, COMPOSITIONS AND ARTICLES OF MANUFACTURE

Anti-PD-1 antibodies

Antibodies to programmed cell death protein 1

Methods of using bispecific CD33 and CD3 binding proteins

METHODS FOR TREATING CANCER USING COMBINATIONS OF ANTI-BTNL2 AND IMMUNE CHECKPOINT BLOCKADE AGENTS

Anti-TIM-3 antibodies and uses thereof

Human anti-semaphorin 4D antibody

ANTI-TIGIT ANTIBODIES AND METHODS OF USE

Methods of treating IgA nephropathy by administering an anti-APRIL (a proliferation-inducing ligand) antibody molecule

Compositions and methods for antibodies targeting BMP6

Anti-PCNA monoclonal antibodies and use thereof

Tau immunotherapy

PREVENTION AND TREATMENT OF SYNUCLEINOPATHIC AND AMYLOIDOGENIC DISEASE